跳至主要内容
临床试验/JPRN-jRCT1060190007
JPRN-jRCT1060190007进行中(未招募)未知

An observational study in patients who received nivolumab preoperatively for stage 1 non-small cell lung cancer considered as high-risk of relapse

Okada Morihito0 个研究点目标入组 50 人开始时间: 2019年6月18日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1.Patients enrolled and received nivolumab therapy in the POTENTIAL study.
  • 2.Subjects who were fully informed beforehand about their participation in this observational study and agreed to participate in the study in writing.

排除标准

  • 1.Patients who are limited, or predicted to be limited, for participation of this study by geographic or social factors during the study period.

研究者

发起方
Okada Morihito

相似试验